Introduction: HPV infection has a prime etiologic role in development and progression of
cervical cancer, one of the most frequent forms of cancer among women in developing …

Background: There are therapeutic dilemmas regarding fertility-preserving treatment among
young women with well-differentiated endometrial carcinoma. Materials and Methods …

Methods: This cross-sectional study was performed on a sample of patients with
gynecological cancers including uterine, ovarian, cervical, and vulvovaginal attending a …

OBJECTIVE: To compare the efficacy of methotrexate and actinomycin D as single agents in
first-line chemotherapy for women with low-risk gestational trophoblastic neoplasia (LR …

Aim: The objective of this study was to compare the histological findings of dilatation and
curettage (D&C) with those on subsequent hysterectomy in patients with abnormal uterine …

Background Chemotherapy and surgery have been the mainstays of epithelial ovarian
cancer (EOC) treatment so far. Cellular immunotherapies such as CAR T cell therapy have …

Background The lymphovascular space invasion (LVSI) is suggested as a prognostic factor
for endometrial cancer in many studies, but it has not yet been employed in FIGO staging …

Methotrexate and dactinomycin are efficient drugs in the treatment of patients with low‐risk
gestational trophoblastic neoplasia (LRGTN). To compare the effectiveness of these two …

Background: Ovarian neoplasms are an important cause of morbidity and mortality in
women. The surgical management of ovarian neoplasms depends on their correct …

Objectives Methotrexate (MTX) and Actinomycin-D (Act-D) are effective drugs used in the
treatment of low-risk gestational trophoblastic neoplasia (LRGTNs). The aim of the present …